
    
      The objective of this feasibility study is to investigate the safety of the AMPLATZER
      Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are
      hemodynamically significant and are either isolated or in conjunction with other congenital
      heart defects in infants and children.
    
  